Related Experiment Video
Updated: Dec 22, 2025

05:18
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
1.8K
In situ decompression vs conservative treatment for mild ulnar neuropathy at the elbow
Sander M Pompe1,2, Tobien Schreuder1,2, Laurien L Teunissen3,4
1Department of Neurology, Zuyderland Medisch Centrum, Sittard-Geleen, The Netherlands.
Muscle & Nerve
|May 6, 2020
Summary
For mild ulnar neuropathy at the elbow (UNE), surgery offers faster symptom relief than conservative treatment. However, long-term outcomes show no significant difference between the two approaches.
Area of Science:
- Neurology
- Orthopedic Surgery
Background:
- The optimal treatment for mild ulnar neuropathy at the elbow (UNE) remains unclear.
- There is a lack of comparative trials between surgical and conservative management for mild UNE.
Purpose of the Study:
- To compare the efficacy of in situ decompression versus conservative treatment for mild ulnar neuropathy at the elbow.
- To evaluate short-term and long-term symptom improvement in patients with mild UNE.
Main Methods:
- A randomized controlled trial was conducted with 117 patients diagnosed with mild UNE.
- Patients were assigned to either in situ decompression surgery or conservative treatment.
- Symptom improvement was assessed at 3 months (short-term) and 6-12 months (long-term) follow-up.
Main Results:
- Surgical intervention showed a higher rate of subjective symptom improvement at short-term follow-up (85% vs. 50%).
- No significant difference in symptom improvement was observed between surgical and conservative groups at long-term follow-up.
- The odds ratio for short-term improvement with surgery was 5.6 (P < .001).
Conclusions:
- In situ decompression may provide quicker symptom relief for mild UNE compared to conservative care.
- Long-term outcomes for mild UNE are similar between surgical and conservative treatments.
- The choice of treatment for mild UNE should consider the patient's preference for rapid symptom relief versus long-term equivalence.

